Eprosartan Mesylate | Interleukin Related interleukin-related.com

Product Name :
Eprosartan Mesylate

Search keywords :
Eprosartan (mesylate)

drugId :
null

Target Vo:
Angiotensin II Receptor Type 1

Target Vo Short Name :
AT1

Moa_Name:
Angiotensin II Receptor Type 1 antagonists

First Approval Country :
United States

First Approval Date Filter:
1997

Origin Company_Name :
Abbvie Inc

Active Company_Name :
Abbott Healthcare Products Bv

Active Indication_Name:
Hypertension

In Active Indication_Name:
Essential Hypertension

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:
Approved

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Anti-Human IL-17A manufacturer
Gosuranemab Biological Activity
RUNX Antibody: RUNX Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 49 kDa, targeting to RUNX. It can be used for WB,IHC-F,IHC-P,ICC/IF,IP assays with tag free, in the background of Human, Mouse, Rat.

Author: Interleukin Related

Related Posts